Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
The Lancet. Infectious Diseases|March 10, 2022
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safeHannah G Rosenblum, Julianne Gee, Ruiling Liu, et al.Frontiers in Immunology|August 1, 2022
Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced MalignanciesHao Huang, Ling Peng, Bicheng Zhang, et al.Pediatrics|April 21, 2023
COVID-19 Vaccine Safety First Year Findings in AdolescentsElisabeth M Hesse, Anne Hause, Tanya Myers, et al.Pharmacoepidemiology and Drug Safety|March 28, 2026
Surveillance of Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccines in the Vaccine Adverse Event Reporting System-United States, July 1, 2015-September 30, 2023Pedro L Moro, Brittney Romanson, Aynalem Getahun, et al.Research Square|February 23, 2021
The Prognostic Value of Myocardial Injury in COVID-19 Patients and Associated CharacteristicsJian He, Bicheng Zhang, Quan Zhou, et al.Vaccine|January 25, 2023
The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC's COVID-19 pandemic responseTanya R Myers, Paige L Marquez, Julianne M Gee, et al.Frontiers in Cardiovascular Medicine|November 1, 2021
Additional Value of Non-contrast Chest CT in the Prediction of Adverse Cardiovascular Events in Patients With Novel Coronavirus Disease 2019 (COVID-19)Shuang Li, Xiaojun Wang, Hongyao Hu, et al.Pharmacoepidemiology and Drug Safety|May 15, 2026
Atypical Shoulder Pain and Dysfunction After Vaccinations Reported to the Vaccine Adverse Event Reporting System (VAERS) January 1, 2018, Through October 31, 2022Elaine R Miller, Paige Marquez, Getahun Aynalem, et al.Pediatrics|May 18, 2022
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 YearsAnne M Hause, David K Shay, Nicola P Klein, et al.Therapeutic Advances in Medical Oncology|July 24, 2023
Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populationsJun Wang, Bicheng Zhang, Ling Peng, et al.Pageof 13